These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21370269)

  • 1. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
    Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
    Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of change in early Huntington's disease: a clinicometric analysis.
    Meyer C; Landwehrmeyer B; Schwenke C; Doble A; Orth M; Ludolph AC;
    Mov Disord; 2012 Jan; 27(1):118-24. PubMed ID: 22095693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults.
    Louis ED; Anderson KE; Moskowitz C; Thorne DZ; Marder K
    Arch Neurol; 2000 Sep; 57(9):1326-30. PubMed ID: 10987900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Oct; 28(12):1717-23. PubMed ID: 24166899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
    Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
    J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
    Moss DJH; Pardiñas AF; Langbehn D; Lo K; Leavitt BR; Roos R; Durr A; Mead S; ; ; Holmans P; Jones L; Tabrizi SJ
    Lancet Neurol; 2017 Sep; 16(9):701-711. PubMed ID: 28642124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of homozygote allele carriers in Huntington disease.
    Cubo E; Martinez-Horta SI; Santalo FS; Descalls AM; Calvo S; Gil-Polo C; Muñoz I; Llano K; Mariscal N; Diaz D; Gutierrez A; Aguado L; Ramos-Arroyo MA;
    Neurology; 2019 Apr; 92(18):e2101-e2108. PubMed ID: 30867264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unified Huntington's disease rating scale: clinical practice and a critical approach.
    Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
    Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the impact of education on Huntington's disease?
    López-Sendón JL; Royuela A; Trigo P; Orth M; Lange H; Reilmann R; Keylock J; Rickards H; Piacentini S; Squitieri F; Landwehrmeyer B; Witjes-Ane MN; Jurgens CK; Roos RA; Abraira V; de Yébenes JG;
    Mov Disord; 2011 Jul; 26(8):1489-95. PubMed ID: 21432905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.
    Killoran A; Biglan KM; Jankovic J; Eberly S; Kayson E; Oakes D; Young AB; Shoulson I
    Neurology; 2013 May; 80(22):2022-7. PubMed ID: 23624566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.
    Marder K; Gu Y; Eberly S; Tanner CM; Scarmeas N; Oakes D; Shoulson I;
    JAMA Neurol; 2013 Nov; 70(11):1382-8. PubMed ID: 24000094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrastriatal degeneration correlates with deficits in the motor domain subscales of the UHDRS.
    Galvez V; Ramírez-García G; Hernandez-Castillo CR; Bayliss L; Díaz R; Lopez-Titla MM; Campos-Romo A; Fernandez-Ruiz J
    J Neurol Sci; 2018 Feb; 385():22-29. PubMed ID: 29406908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
    Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
    Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis.
    Nopoulos S; Reasoner EE; Ogilvie AC; Killoran A; Schultz JL
    Parkinsonism Relat Disord; 2024 Feb; 119():105954. PubMed ID: 38142629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
    Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease.
    Zielonka D; Ren M; De Michele G; Roos RAC; Squitieri F; Bentivoglio AR; Marcinkowski JT; Landwehrmeyer GB
    Parkinsonism Relat Disord; 2018 Apr; 49():42-47. PubMed ID: 29326033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.